Name:
Burkholderia diffusa Vanlaere et al. 2008
DSM No.:
23434, Type strain
Strain designation:
AU1075, O85
Other collection no.
or WDCM no.:
CCUG 54558, LMG 24065
Isolated from:
sputum of patient with cystic fibrosis
Country:
United States of America
Date of sampling:
before 15.03.2010
Nagoya Protocol Restrictions:
There are NO known Nagoya Protocol restrictions for this strain.
History:
<- CCUG <- E. Vanlaere, LMG <- J. J. LiPuma
Genbank accession numbers:
16S rRNA gene: AM747629
Cultivation conditions:
Medium 535 , 30°C
or
Medium 693 , 30°C
Complete DSMZ Media List
Summary and
additional information:
<- CCUG <- E. Vanlaere, LMG <- J. J. LiPuma. Sputum of patient with cystic fibrosis; USA. Type strain. Sequence accession no. 16S rRNA gene: AM747629. (Medium 535 or Medium 693, 30°C).
For detailed information:
Risk group:
2 (classification according to German TRBA)
Restrictions:
Act dealing with the prevention & control of infectious diseases in man (Infektionsschutzgesetz), Category A1
Supplied as:
Delivery form Prices
Price Category for this culture: 1
Freight and handling charges will be added. See price list.
Note: Freight charges for Risk Group 2 microorganisms will apply.
Other cultures:
All DSMZ cultures of the species
Print data sheet
Add to CartOpen Pricelist
Help Topics
FAQOrder & DeliverySafetyQuality assurance
Phenotypic information about Burkholderia diffusa DSM 23434
Nomenclatural information about Burkholderia diffusa
